Do you want to read an article? Please log in or register.
Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry
Epilepsy
RECOMMENDED
Related content
Epilepsy
Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures
Epilepsia.
Fogarasi A, Flamini R, Milh M, Phillips S, Yoshitomi S, Patten A, Takase T, Laurenza A, Ngo LY
doi: 10.1111/epi.16413.
Epilepsy
Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies
Epilepsia.
Rektor I, Krauss GL, Inoue Y, Kaneko S, Williams B, Patten A, Malhotra M, Laurenza A, Wechsler RT
doi: 10.1111/epi.16573.
Epilepsy
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307
Epilepsia.
Krauss GL, Perucca E, Kwan P, Ben-Menachem E, Wang XF, Shih JJ, Patten A, Yang H, Williams B, Laurenza A
doi: 10.1111/epi.14044.
RECOMMENDED
Epilepsy
Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Epilepsia.
Steinhoff BJ, Patten A, Williams B, Malhotra M
doi: 10.1111/epi.16428.
Epilepsy
Quantifying the burden of generalized tonic-clonic seizures in patients with drug-resistant epilepsy
Epilepsia.
Sheikh SR, Thompson N, Frech F, Malhotra M, Jehi L
doi: 10.1111/epi.16603.
EpilepsyMigraine and Headache
Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial
Epilepsia.
Vossler DG, Wechsler RT, Williams P, Byrnes W, Therriault S;
ALEX-MT study group
doi: 10.1111/epi.13502.
RECOMMENDED
Epilepsy
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Epilepsia.
Sperling MR, Klein P, Aboumatar S, Gelfand M, Halford JJ, Krauss GL, Rosenfeld WE, Vossler DG, Wechsler R, Borchert L, Kamin M
doi: 10.1111/epi.16525.
Epilepsy
Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study
Epilepsia.
Trinka E, Ben-Menachem E, Kowacs PA, Elger C, Keller B, Löffler K, Rocha JF, Soares-da-Silva P
doi: 10.1111/epi.13993.
Epilepsy
Safety and Tolerability of Adjunctive Eslicarbazepine Acetate in Pediatric Patients (Aged 4-17 Years) With Focal Seizures
J Child Neurol.
Mintz M, Pina-Garza JE, Wolf SM, McGoldrick PE, Józwiak S, Grinnell T, Cantu D, Costa R, Moreira J, Li Y, Blum D
doi: 10.1177/0883073819890997.